The Lancet Neurology in conversation with
Skupno trajanje:
12 h 20 min
Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy
The Lancet Neurology in conversation with
19:22
Marialuisa Gandolfi on the management of chronic pain in Parkinson's disease
The Lancet Neurology in conversation with
12:13
Michael Tymianski on neuroprotection in stroke
The Lancet Neurology in conversation with
24:47
Elizabeth Finger on oxytocin for apathy in frontotemporal dementia
The Lancet Neurology in conversation with
18:13
The Lancet Neurology Editors on advances in neurology in 2024
The Lancet Neurology in conversation with
17:30
Florian Krismer and Elizabeth Coon on multiple system atrophy
The Lancet Neurology in conversation with
17:14
Suvankar Pal on the motor neuron disease trial MND-SMART
The Lancet Neurology in conversation with
17:50
Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis
The Lancet Neurology in conversation with
19:00
Alex Iranzo on sleep and Parkinson's disease
The Lancet Neurology in conversation with
16:44
Adrian Owen on detecting awareness after acute brain injury
The Lancet Neurology in conversation with
17:19
Glenn Nielsen on specialist physiotherapy for people with functional motor disorder
The Lancet Neurology in conversation with
15:28
Sanjay Sisodiya on climate change and brain health
The Lancet Neurology in conversation with
20:48
Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy
The Lancet Neurology in conversation with
23:28
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system
The Lancet Neurology in conversation with
25:18
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders
The Lancet Neurology in conversation with
12:20
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy
The Lancet Neurology in conversation with
21:45
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury
The Lancet Neurology in conversation with
18:24
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
The Lancet Neurology in conversation with
24:09
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations
The Lancet Neurology in conversation with
26:34
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis
The Lancet Neurology in conversation with
14:42
William Jagust on amyloid β and cognition
The Lancet Neurology in conversation with
13:36
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury
The Lancet Neurology in conversation with
14:34
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases
The Lancet Neurology in conversation with
17:20
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma
The Lancet Neurology in conversation with
18:38
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation
The Lancet Neurology in conversation with
15:20
Kerstin Hellwig on family planning considerations in MS
The Lancet Neurology in conversation with
14:24
Geraldine Dawson on advances in the prediction of autism during infancy
The Lancet Neurology in conversation with
24:34
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
The Lancet Neurology in conversation with
08:45
Beau Ances on amyloid biomarkers in Alzheimer’s
The Lancet Neurology in conversation with
11:34
Axel Petzold on the diagnosis and classification of optic neuritis
The Lancet Neurology in conversation with
20:03
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery
The Lancet Neurology in conversation with
14:37
Jerome Siegel on sleep habits
The Lancet Neurology in conversation with
43:50
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy
The Lancet Neurology in conversation with
17:13
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
The Lancet Neurology in conversation with
22:58
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies
The Lancet Neurology in conversation with
18:52
Mark Hallett on functional neurological disorder
The Lancet Neurology in conversation with
08:43
Eva Feldman on advances in understanding ALS
The Lancet Neurology in conversation with
22:43
Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's
The Lancet Neurology in conversation with
27:15
John Collinge on a treatment for CJD
The Lancet Neurology in conversation with
14:45
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
The Lancet Neurology in conversation with
07:55
